SOPHiA GENETICS and AstraZeneca Spain Commit to Increasing Ovarian Cancer Testing in Spain
SOPHiA GENETICS and AstraZeneca Spain expand HRD testing program to support molecular diagnosis of ovarian cancer in Spain BOSTON and
Read MoreSOPHiA GENETICS and AstraZeneca Spain expand HRD testing program to support molecular diagnosis of ovarian cancer in Spain BOSTON and
Read MoreNATICK, Mass., Jan. 2, 2024 /PRNewswire/ — Allorion Therapeutics (“Allorion”), a US and China-based biotechnology company that focuses on the
Read MoreThe three companies will collaborate to improve global access to advanced cancer testing and data, broadening access to cutting-edge science
Read MoreNEW DELHI, April 20, 2022 /PRNewswire/ —Â India-Sweden Healthcare Innovation Centre, a collaboration between the Swedish Trade Commissioner’s Office, AIIMS New
Read MoreBANGALORE, India, March 11, 2022 /PRNewswire/ —Â This World Kidney Day, Indian Society of Nephrology (ISN), the largest professional organization of
Read MoreMOSCOW, Feb. 14, 2022 /PRNewswire/ — The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), R-Pharm group and AstraZeneca
Read More